CPC A61K 9/14 (2013.01) [A61K 8/025 (2013.01); A61K 8/042 (2013.01); A61K 8/85 (2013.01); A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 9/1647 (2013.01); A61K 9/5031 (2013.01); A61K 31/05 (2013.01); A61K 31/167 (2013.01); A61K 31/245 (2013.01); A61K 31/445 (2013.01); A61K 31/765 (2013.01); A61L 27/18 (2013.01); A61L 27/52 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); A61K 9/0019 (2013.01); A61K 2800/412 (2013.01); A61K 2800/54 (2013.01); A61K 2800/654 (2013.01); A61K 2800/91 (2013.01)] | 10 Claims |
1. An implant or filler composition comprising a biodegradable, injectable gel and further comprising microparticles, each microparticle comprising polycaprolactone (PCL) and having:
i) homogenous density and form,
ii) homogenous PCL content throughout the microparticle, and
iii) essentially spherical and smooth surface,
wherein at least 80 weight percent of the microparticles has a diameter distribution range between 25 and 75 μm.
|